Life Science Analytics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Market Report Covers Global Life Science Analytics Companies and is Segmented by Product Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), Application (Research and Development, Supply Chain Analytics, Sales and Marketing, and Other Applications), Component (Services and Software), End User (Clinical Research Institutions, Pharmaceutical and Biotechnology Companies, Medical Device Companies, and Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Life Science Analytics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Life Science Analytics Market Size

Life Sciences Analytics Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 11.91 Billion
Market Size (2030) USD 17.27 Billion
CAGR (2025 - 2030) 7.71 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Life Sciences Analytics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Life Sciences Analytics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Life Science Analytics Market Analysis

The Life Sciences Analytics Market size is estimated at USD 11.91 billion in 2025, and is expected to reach USD 17.27 billion by 2030, at a CAGR of 7.71% during the forecast period (2025-2030).

The life sciences analytics industry is undergoing a fundamental transformation as organizations increasingly recognize the strategic value of life science data-driven decision-making. This shift is particularly evident in the European region, where, according to the 2023 ISG Provider Lens Life Sciences Digital Services Report, companies are actively pursuing analytics solutions to enhance their marketing initiatives and optimize supply chain operations. The integration of advanced analytics capabilities has become a cornerstone of modern life sciences operations, enabling organizations to process and analyze vast amounts of complex data more efficiently than ever before. This transformation is further accelerated by the growing adoption of cloud-based platforms and the increasing focus on real-world evidence generation.


The technological landscape of data analytics in life sciences continues to evolve rapidly, with artificial intelligence and machine learning taking center stage in driving innovation. In March 2023, Databricks launched its new Lakehouse platform specifically designed for healthcare and life sciences, representing a significant advancement in data management and analytics capabilities. This platform exemplifies the industry's movement toward integrated solutions that can handle multiple aspects of data analytics, from basic data management to advanced AI applications. The platform's introduction has sparked a wave of similar innovations across the industry, as companies seek to develop more sophisticated analytical tools.


Strategic consolidation and partnerships have emerged as key trends shaping the market landscape. In February 2023, Warburg Pincus acquired Pharma Intelligence, demonstrating the growing interest of major investment firms in the life sciences analytics sector. This acquisition, supported by Mubadala Investment Company, highlights the increasing recognition of data analytics as a crucial component of pharmaceutical research and development. The industry has witnessed a surge in similar strategic moves, with companies forming alliances to enhance their analytical capabilities and expand their market presence.


The future outlook for life sciences big data appears promising, driven by the increasing complexity of clinical research and the need for more sophisticated analytical tools. As of early 2024, the industry maintains a robust pipeline of research activities, with over 7,600 active clinical studies and more than 1,400 actively recruiting trials globally. This substantial volume of ongoing research underscores the growing demand for advanced analytics solutions capable of handling large-scale data analysis. The industry is witnessing a shift toward predictive analytics and real-time data processing capabilities, with companies investing heavily in developing tools that can provide actionable insights from complex clinical data sets. The emergence of specialized platforms and tools designed specifically for life sciences applications suggests a trend toward more tailored and sophisticated analytical solutions.

Segment Analysis: By Product Type

Descriptive Analytics Segment in Life Sciences Analytics Market

Descriptive analytics continues to dominate the life sciences analytics market, commanding approximately 50% of the total market share in 2024. This segment's prominence is driven by its fundamental role in collecting and transforming quantitative healthcare data, including hospitalizations, disease cases, and length of hospital stays. Healthcare organizations extensively utilize descriptive analytics tools for data visualization, standardized reporting, and historical trend analysis, which provide clear insights into past medical histories through key performance metrics. The segment's strength lies in its ability to help providers generate comprehensive reports about past events, resource utilization, and patient diagnoses, making it an essential tool for healthcare decision-making and operational efficiency.

Market Analysis of Life Sciences Analytics Market: Chart for By Product Type

Predictive Analytics Segment in Life Sciences Analytics Market

The predictive analytics segment is experiencing remarkable growth in the life sciences analytics market, projected to expand at approximately 9% CAGR from 2024 to 2029. This impressive growth trajectory is driven by the segment's ability to deliver actionable insights and forecast future outcomes based on historical data patterns. Healthcare organizations are increasingly adopting predictive analytics tools to stay ahead of poor outcomes, resource shortages, and optimize patient care. The technology's capability to identify patterns and trends that inform social distancing guidelines and other healthcare measures has become particularly valuable. Additionally, the adoption of predictive analytics in healthcare enterprises has demonstrated significant benefits in cost reduction and patient satisfaction improvement, making it an increasingly attractive solution for healthcare providers and life science companies.

Remaining Segments in Product Type Segmentation

The prescriptive analytics segment completes the product type segmentation of the life sciences analytics market, offering sophisticated techniques and tools that leverage business rules, algorithms, machine learning, and computational modeling procedures. This segment processes inputs from various data sets, including historical and transactional data, real-time data feeds, and Big Data, to provide actionable recommendations. The growing importance of Big Data analytics and increasing adoption of life science business intelligence solutions continue to drive the segment's development. Prescriptive analytics plays a crucial role in optimizing decision-making processes and improving operational efficiency across the life sciences industry.

Segment Analysis: By Application

Sales and Marketing Segment in Life Sciences Analytics Market

The Sales and Marketing segment continues to dominate the life sciences analytics market, holding approximately 33% market share in 2024. This segment's prominence is driven by the increasing adoption of analytical solutions in sales and marketing functions of organizations for improving sales productivity and designing effective marketing campaigns. Analytics solutions help companies improve their marketability to new communities and patient pools, while enabling quick data-driven decisions in pharmaceutical and healthcare sectors. The integration of advanced analytics and artificial intelligence has revolutionized how companies approach their sales strategies and marketing campaigns, leading to more targeted and efficient customer engagement approaches.

Research and Development Segment in Life Sciences Analytics Market

The Research and Development segment is emerging as the fastest-growing segment in the life sciences analytics market, projected to grow at approximately 9% during 2024-2029. This remarkable growth is primarily attributed to the rising adoption of analytical solutions in drug discovery and development, along with clinical trial management systems. The segment's growth is further accelerated by the increasing drug pipeline of life science organizations and the growing demand for efficient data management in clinical trials. Advanced analytics platforms are becoming increasingly crucial in streamlining research processes, reducing development costs, and improving the success rates of clinical trials through better data utilization and predictive modeling capabilities.

Remaining Segments in Life Sciences Analytics Market by Application

The Supply Chain Analytics and Other Applications segments also play vital roles in shaping the life sciences analytics market landscape. Supply Chain Analytics helps enterprises achieve growth and enhance profitability by utilizing derived insights for making strategic decisions in inventory management and distribution networks. The Other Applications segment, which includes regulatory compliance, pharmacovigilance, and manufacturing solutions, contributes significantly by enabling organizations to maintain compliance standards and ensure drug safety monitoring. These segments collectively enhance the overall efficiency of life science operations by providing comprehensive analytical solutions across different functional areas.

Segment Analysis: By Component

Services Segment in Life Sciences Analytics Market

The Services segment has established itself as the dominant force in the global life sciences analytics market, commanding approximately 54% of the total market share in 2024. This segment's leadership position can be attributed to the increasing demand for analytical services driven by the massive volume of medical data being generated, including patient records, appointment schedules, and clinical trial information. Healthcare providers worldwide are increasingly recognizing the critical importance of efficient data handling and management services. The growth in this segment is further accelerated by various government initiatives and private entities pushing for healthcare industry digitalization. Major technology companies are actively expanding their service offerings through cloud-based platforms, specialized healthcare analytics solutions, and comprehensive data management services. The segment's robust performance is also supported by the rising adoption of real-time analytics services, machine learning capabilities, and artificial intelligence-driven solutions in healthcare settings.

Software Segment in Life Sciences Analytics Market

The Software segment plays a crucial role in the life sciences analytics market by providing essential tools for data analysis and decision support at both patient and business levels. This segment is experiencing significant growth as healthcare organizations increasingly adopt electronic record keeping and other digital data collection methods. The demand for software solutions is being driven by the need to analyze and interpret the growing volume of healthcare data being collected in real time. Software providers are focusing on developing more sophisticated solutions that can integrate with existing healthcare systems while offering advanced analytics capabilities. The segment is seeing particular innovation in areas such as predictive analytics, artificial intelligence integration, and real-time monitoring capabilities. Healthcare enterprises are increasingly investing in software solutions that can help them optimize their operations, improve patient outcomes, and make more informed clinical decisions. The continuous evolution of healthcare technology and the increasing emphasis on data-driven decision-making are expected to maintain strong growth momentum in this segment.

Segment Analysis: By End User

Pharmaceutical and Biotechnology Companies Segment in Life Sciences Analytics Market

The pharmaceutical and biotechnology companies segment dominates the global life sciences analytics market, holding approximately 51% market share in 2024. This significant market position is driven by the increasing adoption of analytical solutions in drug discovery and development processes, as well as the growing need for data-driven decision making in clinical trials. Major pharmaceutical companies are increasingly leveraging advanced analytics platforms to optimize their research and development activities, improve clinical trial outcomes, and enhance their commercial operations. The segment's strong position is further reinforced by the rising implementation of real-world evidence solutions, predictive analytics for drug development, and AI-powered platforms that help accelerate the drug discovery process while reducing costs.

Medical Device Companies Segment in Life Sciences Analytics Market

The medical device companies segment is projected to experience the fastest growth in the life sciences analytics market during the forecast period 2024-2029, with an expected growth rate of approximately 9%. This rapid growth is attributed to the increasing adoption of analytics solutions for product innovation, quality management, and regulatory compliance. Medical device manufacturers are increasingly implementing advanced analytics platforms to optimize their manufacturing processes, enhance product quality, and improve supply chain efficiency. The segment's growth is further driven by the rising demand for predictive maintenance solutions, real-time monitoring capabilities, and data-driven insights that help in product development and market positioning. The integration of IoT devices and the growing focus on personalized medical devices are also contributing to the increased adoption of analytics solutions in this segment.

Remaining Segments in End User Market

The clinical research institutions and other end users segments also play crucial roles in shaping the life sciences analytics market landscape. Clinical research institutions are increasingly adopting analytics solutions to streamline their research processes, manage large volumes of clinical data, and enhance the efficiency of clinical trials. These institutions leverage advanced analytics platforms for patient recruitment, trial management, and research outcome analysis. The other end users segment, which includes contract research organizations and academic institutes, contributes to market growth through their increasing focus on data-driven research methodologies and the adoption of analytics solutions for improving research outcomes. Both segments are witnessing growing implementation of cloud-based analytics platforms and AI-powered solutions to enhance their research capabilities and operational efficiency.

Life Sciences Analytics Market Geography Segment Analysis

Life Sciences Analytics Market in North America

North America represents a dominant force in the life sciences market size, characterized by advanced healthcare infrastructure and significant technological adoption. The region's market landscape is shaped by the presence of major pharmaceutical companies, biotechnology firms, and research institutions across the United States, Canada, and Mexico. The robust healthcare ecosystem, coupled with substantial investments in research and development activities, continues to drive the adoption of analytics solutions. The region benefits from well-established regulatory frameworks, an increasing focus on personalized medicine, and growing demand for improved patient outcomes through data-driven decision-making.

Market Analysis of Life Sciences Analytics Market: Forecasted Growth Rate by Region

Life Sciences Analytics Market in United States

The United States maintains its position as the largest market for life sciences analytics in North America, driven by extensive pharmaceutical research activities and technological innovation. The country's market dominance is supported by the presence of leading pharmaceutical companies, advanced healthcare infrastructure, and significant investments in research and development. With approximately 78% of the North American market share in 2024, the United States continues to lead in the adoption of advanced analytics solutions. The country's strong focus on precision medicine, clinical trial optimization, and patient outcome improvements further reinforces its market leadership position.

Life Sciences Analytics Market Growth Dynamics in United States

The United States also emerges as the fastest-growing market in North America, with a projected growth rate of approximately 7% during 2024-2029. This growth is fueled by the increasing adoption of artificial intelligence and machine learning in healthcare analytics, rising demand for real-world evidence solutions, and expanding applications in drug discovery and development. The country's robust ecosystem of healthcare startups, technology providers, and research institutions continues to drive innovation in analytics solutions. The growing emphasis on value-based healthcare and the need for efficient clinical trial management further accelerate market expansion.

Life Sciences Analytics Market in Europe

Europe represents a significant market for life sciences analytics, characterized by strong research capabilities and innovative healthcare systems across Germany, the United Kingdom, France, Italy, and Spain. The region's market is driven by increasing digitalization of healthcare services, growing adoption of precision medicine approaches, and rising investments in pharmaceutical research. The presence of established pharmaceutical companies, research institutions, and technology providers creates a robust ecosystem for analytics adoption. European countries' focus on healthcare quality improvement and cost optimization continues to drive the demand for advanced analytics solutions.

Life Sciences Analytics Market in Germany

Germany stands as the largest market for life sciences analytics in Europe, supported by its strong pharmaceutical industry and technological infrastructure. The country's leadership position is reinforced by its robust healthcare system, significant research and development investments, and advanced medical technology sector. With approximately 20% of the European market share in 2024, Germany continues to drive innovation in analytics applications. The country's emphasis on digital health initiatives and Industry 4.0 integration in healthcare further strengthens its market position.

Life Sciences Analytics Market Growth Dynamics in United Kingdom

The United Kingdom emerges as the fastest-growing market in Europe, with a projected growth rate of approximately 9% during 2024-2029. This growth is driven by increasing investments in healthcare digitalization, rising adoption of real-world evidence solutions, and a growing focus on personalized medicine approaches. The country's strong research infrastructure and supportive regulatory environment facilitate the adoption of advanced analytics solutions. The UK's commitment to healthcare innovation and emphasis on improving patient outcomes through data-driven approaches continues to accelerate market expansion.

Life Sciences Analytics Market in Asia-Pacific

The Asia-Pacific region represents a dynamic market for life sciences analytics, encompassing diverse healthcare landscapes across China, Japan, India, Australia, and South Korea. The region's market is characterized by rapid digitalization of healthcare services, increasing investments in pharmaceutical research, and growing adoption of advanced analytics solutions. The presence of emerging biotechnology companies, research institutions, and an increasing focus on healthcare quality improvement drives market growth. The region's large patient population and growing healthcare expenditure create significant opportunities for analytics adoption.

Life Sciences Analytics Market in China

China emerges as the largest market for life sciences analytics in the Asia-Pacific region, driven by its extensive healthcare system and rapid technological advancement. The country's market leadership is supported by significant investments in healthcare infrastructure, growing pharmaceutical research activities, and increasing adoption of digital health solutions. The presence of large patient populations and a growing focus on healthcare modernization reinforces China's position in the regional market. The country's emphasis on innovation in healthcare delivery and research continues to drive the adoption of analytics solutions.

Life Sciences Analytics Market Growth Dynamics in India

India stands out as the fastest-growing market in the Asia-Pacific region, driven by rapid digitalization of healthcare services and increasing investments in pharmaceutical research. The country's growth is supported by a strong information technology infrastructure, a growing focus on clinical research, and rising adoption of advanced analytics solutions. The presence of a large patient population and increasing healthcare expenditure creates significant opportunities for market expansion. India's emerging biotechnology sector and focus on healthcare innovation continue to drive the adoption of analytics solutions.

Life Sciences Analytics Market in Middle East & Africa

The Middle East & Africa region presents a growing market for life sciences analytics, with significant developments across GCC countries and South Africa. The region's market is characterized by increasing healthcare digitalization initiatives, growing investments in healthcare infrastructure, and rising adoption of advanced analytics solutions. Among the countries in this region, GCC emerges as the largest market while South Africa shows the fastest growth potential. The region's focus on healthcare modernization and increasing pharmaceutical research activities continues to drive the adoption of analytics solutions.

Life Sciences Analytics Market in South America

South America demonstrates growing potential in the life sciences analytics market, with Brazil and Argentina leading the regional development. The market is characterized by increasing healthcare digitalization efforts, growing pharmaceutical research activities, and rising adoption of analytics solutions. Brazil emerges as both the largest and fastest-growing market in the region, driven by its extensive healthcare system and increasing investments in research and development. The region's focus on improving healthcare delivery and research capabilities continues to drive the adoption of advanced analytics solutions.

Life Science Analytics Industry Overview

Top Companies in Life Sciences Analytics Market

The life sciences analytics companies market features prominent players such as Accenture, Cognizant, IBM, Oracle, IQVIA, and SAS Institute leading the innovation curve. These companies are heavily investing in research and development to enhance their analytical capabilities, particularly in areas of artificial intelligence, machine learning, and cloud computing. Strategic partnerships and collaborations with healthcare providers, pharmaceutical companies, and research institutions have become increasingly common to expand service offerings and geographical reach. Companies are focusing on developing integrated platforms that combine data management, analytics, and visualization capabilities to provide comprehensive solutions. The market is characterized by continuous product launches and platform enhancements, with companies emphasizing the development of specialized solutions for clinical trials, drug development, and patient outcomes. Operational agility is being achieved through cloud-based deployments and flexible delivery models, while strategic acquisitions are being pursued to strengthen technological capabilities and expand market presence.

Market Dominated by Global Technology Leaders

The life sciences analytics market structure is characterized by the presence of large global technology conglomerates alongside specialized analytics providers. These established players possess extensive resources, robust technological infrastructure, and deep industry expertise, allowing them to offer comprehensive solutions across the healthcare and life sciences value chain. The market shows moderate to high consolidation, with major players continuously expanding their market share through strategic acquisitions and partnerships. Regional players and specialized analytics providers maintain their presence by focusing on specific geographic markets or specialized solutions in areas such as clinical trials or drug development.


The market exhibits strong merger and acquisition activity, with larger companies actively acquiring smaller, innovative firms to enhance their technological capabilities and expand their service portfolios. Technology giants are particularly interested in acquiring companies with specialized healthcare analytics capabilities or unique intellectual property in areas such as artificial intelligence and machine learning. This consolidation trend is driven by the need to achieve economies of scale, expand geographic presence, and acquire specialized expertise in emerging technologies. Companies are also forming strategic alliances and partnerships to combine complementary strengths and offer more comprehensive solutions to clients.

Innovation and Integration Drive Market Success

For incumbent players to maintain and increase their market share, continuous investment in research and development remains crucial, particularly in emerging technologies like artificial intelligence and predictive analytics. Companies need to focus on developing integrated solutions that can seamlessly connect with existing healthcare systems while ensuring data security and regulatory compliance. Building strong relationships with healthcare providers, pharmaceutical companies, and research institutions through strategic partnerships helps in creating sustainable competitive advantages. Additionally, established players must maintain operational flexibility to adapt to changing market demands and regulatory requirements while investing in talent acquisition and development.


New entrants and contenders in the market can gain ground by focusing on specialized niches or underserved geographic markets, developing innovative solutions that address specific industry challenges. Success in this market requires strong technological capabilities, deep domain expertise, and the ability to navigate complex regulatory requirements. Companies must also consider the high concentration of end-users in the pharmaceutical and biotechnology sectors, which necessitates building strong relationships and understanding specific industry needs. The relatively low threat of substitution due to the specialized nature of life sciences analytics provides opportunities for companies to establish strong market positions, though they must remain vigilant about regulatory changes and compliance requirements that could impact market dynamics.

Life Science Analytics Market Leaders

  1. Accenture

  2. IBM Corporation

  3. Oracle Corporation

  4. IQVIA

  5. SAS Institute Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Life Sciences Analytics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Life Science Analytics Market News

  • July 2022: Charles River Associates launched the company's new data analytics suite, the Healthcare Claims Analytics Platform (HCAP), at the World Orphan Drug Congress USA 2022 in Boston. HCAP delivers the power of machine learning and patient analytics to inform about market understanding and support intelligent decision-making.
  • March 2022: Databricks launched the Databricks Lakehouse for Healthcare and Life Sciences. It is a single platform for data management, analytics, and advanced AI use cases like disease prediction, medical image classification, and biomarker discovery.

Life Science Analytics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials
    • 4.2.2 Growing Pressure to Reduce Healthcare Spending and the Need for Improved Patient Outcomes
    • 4.2.3 Emergence of Advanced Analytics Method in Life Science Companies
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Personnel
    • 4.3.2 High Implementation Costs
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD million)

  • 5.1 By Product Type
    • 5.1.1 Descriptive Analytics
    • 5.1.2 Predictive Analytics
    • 5.1.3 Prescriptive Analytics
  • 5.2 By Application
    • 5.2.1 Research and Development
    • 5.2.2 Supply Chain Analytics
    • 5.2.3 Sales and Marketing
    • 5.2.4 Other Applications
  • 5.3 By Component
    • 5.3.1 Services
    • 5.3.2 Software
  • 5.4 By End User
    • 5.4.1 Clinical Research Institutions
    • 5.4.2 Pharmaceutical and Biotechnology Companies
    • 5.4.3 Medical Device Companies
    • 5.4.4 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Accenture
    • 6.1.2 Cognizant
    • 6.1.3 IBM Corporation
    • 6.1.4 MaxisIT Inc.
    • 6.1.5 Oracle Corporation
    • 6.1.6 IQVIA
    • 6.1.7 SAS Institute Inc.
    • 6.1.8 SCIOInspire Corp.
    • 6.1.9 TAKE Solutions Limited
    • 6.1.10 Wipro Limited
    • 6.1.11 Dynata
    • 6.1.12 M3 (EU) Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Life Science Analytics Industry Segmentation

Life sciences analytics refers to any analytical application used in clinical research organizations, pharmaceutical, medical device companies, and various divisions, such as research, supply chain, marketing, pharmacovigilance, and others. 

The life sciences analytics market is segmented by product type (descriptive analytics, predictive analytics, and prescriptive analytics), application (research and development, supply chain analytics, sales and marketing, and other applications), component (services and software), end user (clinical research institutions, pharmaceutical and biotechnology companies, medical device companies, and other end users) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.

By Product Type Descriptive Analytics
Predictive Analytics
Prescriptive Analytics
By Application Research and Development
Supply Chain Analytics
Sales and Marketing
Other Applications
By Component Services
Software
By End User Clinical Research Institutions
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Life Science Analytics Market Research FAQs

How big is the Life Sciences Analytics Market?

The Life Sciences Analytics Market size is expected to reach USD 11.91 billion in 2025 and grow at a CAGR of 7.71% to reach USD 17.27 billion by 2030.

What is the current Life Sciences Analytics Market size?

In 2025, the Life Sciences Analytics Market size is expected to reach USD 11.91 billion.

Who are the key players in Life Sciences Analytics Market?

Accenture, IBM Corporation, Oracle Corporation, IQVIA and SAS Institute Inc. are the major companies operating in the Life Sciences Analytics Market.

Which is the fastest growing region in Life Sciences Analytics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Life Sciences Analytics Market?

In 2025, the North America accounts for the largest market share in Life Sciences Analytics Market.

What years does this Life Sciences Analytics Market cover, and what was the market size in 2024?

In 2024, the Life Sciences Analytics Market size was estimated at USD 10.99 billion. The report covers the Life Sciences Analytics Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Life Sciences Analytics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Life Sciences Analytics Market Research

Mordor Intelligence provides comprehensive insights into the life sciences analytics market. We leverage our extensive expertise in life science market research and industry analysis. Our detailed report examines the convergence of big data analytics in life sciences with emerging technologies. It covers everything from healthcare and life sciences analytics to commercial pharmaceutical analytics. The analysis includes life sciences software companies, pharma analytics companies, and key players driving innovation in life sciences data analytics. This information is available in an easy-to-read report PDF format for download.

Our research offers stakeholders crucial insights into the life sciences market size, industry growth, and various market segments. It explores advanced applications of life sciences predictive analytics and performance analytics. The report details how life science analytics companies are transforming business intelligence frameworks and forecasting methodologies. Stakeholders gain valuable perspectives on life sciences commercial analytics and marketing analytics services. Additionally, it covers emerging trends in pharma data analytics, supported by comprehensive life sciences industry market size data and detailed market assessment frameworks.